Imagen de Portada

TRKing down drug resistance in NTRK fusion‐positive cancers†

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Abigail G Parrish, Frank Szulzewsky
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	The Journal of Pathology
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Acquired NF2 mutation confers resistance to TRK inhibition in an ex vivoLMNA::NTRK1‐rearranged soft‐tissue sarcoma cell model
por: Yanjiang Chen, et al.
Publicado: (2024)

Mitochondrial reprogramming in lung cancer: a therapeutic vulnerability and a strategy for reversing drug resistance
por: Woo Hyun Park
Publicado: (2026)

Infantile Congenital Nevus With Atypical Proliferative Nodules and NTRK Gene Fusion
por: Shuang Xue, et al.
Publicado: (2026)

Comprehensive clinicopathological, molecular, and methylation analysis of mesenchymal tumors with NTRK and other kinase gene aberrations
por: Natálie Klubíčková, et al.
Publicado: (2024)

Large Congenital Melanocytic Nevus With LMNA::NTRK1 Fusion: Expanding Targeted Therapy Options for Congenital Nevi and Melanoma
por: Akanksha Nagarkar, et al.
Publicado: (2025)

PI3 expression predicts recurrence after chemotherapy with DNA‐damaging drugs in gastric cancer
por: Kenji Harada, et al.
Publicado: (2025)

Spitz Spindle Cell/Reed Nevus With SQSTM1 :: NTRK2 Fusion and Atypical Features in an Older Male Patient: A Case Report and Review of Literature
por: Federico Scarfò, et al.
Publicado: (2025)

Deep learning‐based H&E‐derived risk scores in colorectal cancer: associations with tumour morphology, biology, and predicted drug response
por: Nic G Reitsam, et al.
Publicado: (2026)

Downregulation of AATK enhances susceptibility to ferroptosis by promoting endosome recycling in gefitinib‐resistant lung cancer cells
por: Wei‐Chang Lee, et al.
Publicado: (2025)

NKX3‐1‐Expressing Mucous Gland Adenoma With LMNA::NTRK1 Fusion of the Lung: Toward a Spectrum of NKX3‐1‐Expressing NTRK ‐Rearranged Mucinous Neoplasms
por: Mahmut Amori, et al.
Publicado: (2025)

Expanding the clinicopathologic spectrum and genomic landscape of tumors with SMARCA2/4::CREM fusions
por: Joanna Cyrta, et al.
Publicado: (2024)

RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma‐like mesenchymal tumors
por: Marialetizia Motta, et al.
Publicado: (2024)

Exploring the molecular landscape of cutaneous mixed tumors characterized by TRPS1 :: PLAG1 gene fusion
por: Ziyad Alsugair, et al.
Publicado: (2024)

Primary cutaneous NUT carcinoma with BRD4::NUTM1 fusion
por: Ahmed Shah, et al.
Publicado: (2024)

Spitz melanocytic neoplasms with MLPH::ALK fusions: Report of two cases with previously unreported features and literature review
por: Haneen T. Salah, et al.
Publicado: (2024)

Extracellular matrix cancer‐associated fibroblasts promote stromal fibrosis and immune exclusion in triple‐negative breast cancer
por: Xunxi Lu, et al.
Publicado: (2025)

AMIGO2 characterizes cancer‐associated fibroblasts in metastatic colon cancer and induces the release of paracrine active tumorigenic secretomes
por: Yongsong Yong, et al.
Publicado: (2024)

Bile duct tumor thrombus (intraductal polypoid growth)–positive intrahepatic cholangiocarcinoma: clinicopathologic and genomic analysis
por: Ayaka Mitsui, et al.
Publicado: (2026)

A cutaneous spindle cell neoplasm characterized by a COL3A1::PDGFRA fusion
por: James Watkins, et al.
Publicado: (2024)

PRRX1‐fused mesenchymal neoplasm: A novel PRRX1::NCOA1 fusion transcript
por: Xiao Cheng, et al.
Publicado: (2024)

Delta‐like 1 homolog ( DLK1 ) regulates cancer stemness and chemoresistance of ovarian cancer by CD44 / CD133 upregulation
por: Chao‐Cheng Huang, et al.
Publicado: (2026)

Superficial acral calcified chondroid mesenchymal neoplasm harboring an FN1::FGFR2 fusion and review of the literature
por: Isidro Machado, et al.
Publicado: (2024)

Clonal analysis of metachronous double biliary tract cancers
por: Yuko Omori, et al.
Publicado: (2024)

Integrating artificial intelligence ( AI ) into colorectal cancer reporting
por: Konstantin Bräutigam, et al.
Publicado: (2026)

C1GALT1 expression predicts poor survival in osteosarcoma and is crucial for ABCC1 transporter‐mediated doxorubicin resistance
por: Chun‐Wei Liu, et al.
Publicado: (2025)

Case of a CIC::DUX4 fusion gene in a vascular neoplasm extends the spectrum of CIC‐rearranged sarcomas
por: William R. Jeck, et al.
Publicado: (2024)

The emerging role of targeted protein degradation to treat and study cancer
por: Maximillian H Brodermann, et al.
Publicado: (2024)

BMP signalling in colorectal cancer: losing the yin to WNTs yang
por: Eloise Clarkson, et al.
Publicado: (2025)

Metamorphoses in pancreatic cancer precursors: the role of simple mucinous cysts †
por: Paolo Riccardo Camisa, et al.
Publicado: (2025)

A Tc1‐ and Th1‐T‐lymphocyte‐rich tumor microenvironment is a hallmark of MSI colorectal cancer
por: Zhihao Huang, et al.
Publicado: (2025)

Mutation profiling in differential diagnosis between TdT ‐positive high‐grade/large B‐cell lymphoma and B‐lymphoblastic leukaemia/lymphoma
por: Maria‐Myrsini Tzioni, et al.
Publicado: (2025)

AI ‐guided histopathology predicts brain metastasis in lung cancer patients
por: Haowen Zhou, et al.
Publicado: (2024)

Roles of THBS2 + fibroblasts in malignant transformation of colorectal polyp to cancer
por: Qizheng Han, et al.
Publicado: (2026)

Correction to ‘Hourglass, a compass navigating global and regional heterogeneity of pancreatic cancer’
Publicado: (2024)

Upcycling HOXB13 : enhancing prostate cancer detection with a novel antibody †
por: Anke Augspach, et al.
Publicado: (2024)

Clinical outcomes and immune contexture in SMARCA4 ‐deficient gastric cancer patients
por: Mengyao Sun, et al.
Publicado: (2025)

Elevated NPM1 and FBL expression correlates with prostate cancer aggressiveness and progression
por: Sarina Saffarian, et al.
Publicado: (2025)

Stress testing deep learning models for prostate cancer detection on biopsies and surgical specimens
por: Brennan T Flannery, et al.
Publicado: (2024)

Revisionist history uncovers a simplified molecular‐based classification of differentiated thyroid cancer
por: Sylvia L Asa, et al.
Publicado: (2025)

Cancer‐associated fibroblast subtypes in the tumor microenvironment of prostate cancer and associations to patient outcomes
por: Marcus Lunau Blanke, et al.
Publicado: (2026)